Bennett Selby Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.54M | Buy |
51,231
+6,355
| +14% | +$439K | 1.26% | 18 |
|
|
2025
Q1 | $3.12M | Buy |
44,876
+16,651
| +59% | +$1.16M | 1.23% | 19 |
|
|
2024
Q4 | $2.43M | Buy |
28,225
+2,074
| +8% | +$178K | 0.96% | 21 |
|
|
2024
Q3 | $3.11M | Buy |
26,151
+2,614
| +11% | +$311K | 1.31% | 16 |
|
|
2024
Q2 | $3.36M | Buy |
23,537
+1,054
| +5% | +$150K | 1.51% | 15 |
|
|
2024
Q1 | $2.89M | Buy |
22,483
+468
| +2% | +$60.1K | 1.35% | 17 |
|
|
2023
Q4 | $2.28M | Buy |
22,015
+1,676
| +8% | +$173K | 1.17% | 18 |
|
|
2023
Q3 | $1.85M | Buy |
20,339
+653
| +3% | +$59.4K | 1.08% | 20 |
|
|
2023
Q2 | $1.59M | Buy |
19,686
+2,140
| +12% | +$173K | 0.92% | 22 |
|
|
2023
Q1 | $1.4M | Buy |
17,546
+4,574
| +35% | +$364K | 0.91% | 22 |
|
|
2022
Q4 | $878K | Buy |
12,972
+188
| +1% | +$12.7K | 0.66% | 29 |
|
|
2022
Q3 | $637K | Buy |
12,784
+4,580
| +56% | +$228K | 0.51% | 31 |
|
|
2022
Q2 | $457K | Sell |
8,204
-256
| -3% | -$14.3K | 0.35% | 39 |
|
|
2022
Q1 | $470K | Buy |
8,460
+698
| +9% | +$38.8K | 0.28% | 45 |
|
|
2021
Q4 | $435K | Sell |
7,762
-208
| -3% | -$11.7K | 0.25% | 44 |
|
|
2021
Q3 | $383K | Buy |
+7,970
| New | +$383K | 0.25% | 47 |
|